Clinical problems. The lungs

Rheumatic Disease Clinics of North America

Volumn 22, Issue 4, 1996, Pages 825-840

  Silver, R M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTHELIN; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

BLOOD VESSEL TONE; CAUSE OF DEATH; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLITIS; LUNG BLOOD VESSEL; LUNG LAVAGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SURVIVAL; SYSTEMIC SCLEROSIS; VASCULAR DISEASE; LUNG DISEASE;

HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES; LUNG DISEASES, INTERSTITIAL; SCLERODERMA, SYSTEMIC;

EID: 0030277326     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70303-3     Document Type: Article

References (95)

1. A. Akesson A. Scheja A. Lundin Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide Arthritis Rheum 37 1994 729 735
2. M.A. Alpert T.A. Pressly V. Mukerji Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome, and mixed connective tissue disease Am J Cardiol 68 1991 1687 1691
3. M.R. Al-Sabbagh V.D. Steen B.C. Zee Pulmonary arterial histology and morphometry in systemic sclerosis: A case-control autopsy study J Rheumatol 16 1989 1038 1042
4. R.D. Altman T.A. Medsger Jr D.A. Bloch Predictors of survival in systemic sclerosis (scleroderma) Arthritis Rheum 34 1991 403 413
5. 1 and other vasodilator agents in pulmonary hypertension of scleroderma Br Heart J 48 1982 304 305
6. 1 therapy for digital ulcers in scleroderma Can Med Assoc J 126 1982 42 45
7. R.J. Barst L.J. Rubin W.A. Long A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension N Engl J Med 334 1996 296 301
8. R.J. Barst L.J. Rubin M.D. McGoon Survival in primary hypertension with long-term continuous intravenous prostacyclin Ann Intern Med 121 1994 409 415
9. Bolster MB, Ludwicka A, Strange C, et al. Cytokines in bronchoalveolar lavage (BAL) fluid of patients with systemic sclerosis (SSc) [abstract 622]. Abstracts of Scientific Presentations, 58th National Scientific Meeting of American College of Rheumatology, Minneapolis, October 23–27, 1994, p S263.
10. M. Bolster R.M. Silver Systemic sclerosis C.A. Kelley Lung Disease in Rheumatic Disorders. 1993 Baillie`re-Tindall London 79 88
11. T.J. Broekelmann A.H. Limper T.V. Colby Transforming growth factor-β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis Proc Natl Acad Sci USA 88 1991 6642 6646
12. A.D. Cambrey N.K. Harrison K.E. Dawes Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro Am J Respir Cell Mol Biol 11 1994 439 445
13. P. Chanez J.Y. Lacoste B. Guillot Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung Am Rev Respir Dis 147 1993 1497 1502
14. J.F. Cordier Y. Lasne O. Benzerara Pneumopathies interstitielles fibrosantes. Activite´ collage´nolytique du liquide alve´olaire Presse Med 12 1983 1345 1348
15. W.A. D'Angelo J.F. Fries A.T. Masi Pathologic observations in systemic sclerosis (scleroderma): A study of 58 autopsy cases and 58 matched controls Am J Med 46 1969 428 440
16. de la Mata J. M.A. Gomez-Sanchez M. Aranzana Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases Arthritis Rheum 37 1994 1528 1533
17. A. Desmouliere A. Geinoz F. Gabbiani Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts J Cell Biol 122 1993 103 111
18. G. Emmanuel D. Saroja K. Gopinathan Session 11: Acute and chronic fibrotic states: Environmental factors and the diffusing capacity of the lung in progressive systemic sclerosis Chest 69 1976 304 307
19. Y. Enson H.M. Thomas III C.H. Bosken Pulmonary hypertension in interstitial lung disease: Relation of vascular resistance to abnormal lung structure Transactions of the Association of American Physicians 88 1975 248 255
20. J.R. Fineman M.S. Zwass Inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn Acta Paediatr Jpn 37 1995 425 430
21. M.J. Fritzler T.D. Kinsella E. Garbutt The CREST syndrome: A distinct serologic entity with anticentromere antibodies Am J Med 69 1980 520 526
22. J. Gauldie M. Jordana G. Cox Cytokines and pulmonary fibrosis Thorax 48 1993 931 935
23. A. Giaid D. Saleh Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension N Engl J Med 333 1995 214 221
24. S.N. Giri D.M. Hyde M.A. Hollinger Effect of antibody to transforming growth factor-β on bleomycin-induced accumulation of lung collagen in mice Thorax 48 1993 959 966
25. 99mTc-DTPA clearance Respir Med 83 1989 403 414
26. N.K. Harrison R.J. McAnulty P.L. Haslam Evidence of protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosis Thorax 45 1990 606 610
27. N.K. Harrison A.R. Myers B. Corrin Structural features of interstitial lung disease in systemic sclerosis Am Rev Respir Dis 144 1991 706 713
28. G.W. Hunninghake J.E. Gadek O. Kawanami Inflammatory and immune processes in the human lung in health and disease: Evaluation by bronchoalveolar lavage Am J Pathol 97 1979 149 198
29. H.M. Jansen A.J.H. Schutte J.D. Elema Local immune complexes and inflammatory response in patients with chronic interstitial pulmonary disorders associated with collagen vascular diseases Clin Exp Immunol 56 1984 311 320
30. M. Jordana I. Ohno Z. Xing Cytokines in lung and airways fibrosis Reg Immunol 5 1993 201 206
31. N. Khalil O. Berezany M. Sporn Macrophage production of transforming growth factor-β and fibroblast collagen synthesis in chronic pulmonary fibrosis J Exp Med 170 1989 727 737
32. 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: An immunohistochemical study Am J Respir Cell Mol Biol 14 1996 131 138
33. N. Khalil R.N. O'Connor H.W. Unruh Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis Am J Respir Cell Mol Biol 5 1991 155 162
34. N. Khalil C. Whitman L. Zuo Regulation of alveolar macrophage transforming growth factor-β secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat J Clin Invest 92 1993 1812 1818
35. M.B. Kinsella E.A. Smith K.S. Miller Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma Arthritis Rheum 32 1989 577 583
36. G. Konig C. Luderschmidt C. Hammer Lung involvement in scleroderma Chest 85 1984 318 324
37. C. Kouyoumdijan S. Adnot M. Lavame Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats J Clin Invest 94 1994 578 584
38. E.C. Lawrence R.R. Martin R.M. Blaese Increased bronchoalveolar IgG-secreting cells in interstitial lung diseases N Engl J Med 302 1980 1186 1188
39. P. Lee P. Langevitz C.A. Alderdice Mortality in systemic sclerosis (scleroderma) Q J Med (New Series 82) 298 1992 139 148
40. S.M. Levine A. Anzueto J.I. Peters Single lung transplantation in patients with systemic disease Chest 105 1994 837 841
41. 1 and PDGF in scleroderma bronchoalveolar lavage fluid J Rheumatol 22 1995 1876 1883
42. A. Ludwicka M. Trojanowska E.A. Smith Growth and characterization of fibroblasts obtained from bronchoalveolar lavage of scleroderma patients J Rheumatol 19 1992 1716 1723
43. J.P. Lynch III T.J. Standiford M.W. Rolfe Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8 Am Rev Respir Dis 145 1992 1433 1439
44. Y. Martinet W.N. Rom G.R. Grotendorst Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis N Engl J Med 317 1987 202 209
45. J.B. Martinot B. Wallaert P.Y. Hatron Clinical and subclinical alveolitis in collagen vascular diseases: Contribution of α-2 macroglobulin level in BAL fluid Eur Respir J 2 1989 437 443
46. M. Matucci-Cerinic A. Pignone F. Iannone Clinical correlations of plasma angiotensin converting enzyme (ACE) activity in systemic sclerosis: A longitudinal study of plasma ACE level, endothelial injury, and lung involvement Respir Med 84 1990 283 287
47. J. Mitchell J. Woodcock-Mitchell S. Reynolds Alpha-smooth muscle actin in parenchymal cells of bleomycin-injured rat lung Lab Invest 60 1989 643 650
48. Y. Miyazaki K. Araki C. Vesin Expression of a tumor necrosis factor-α transgene in murine lung causes lymphocytic and fibrosing alveolitis J Clin Invest 96 1995 250 259
49. L.W. Moreland K.T. Goldsmith W.J. Russell Transforming growth factor-β within fibrotic scleroderma lungs Am J Med 93 1992 628 636
50. J.M. Morgan M. Griffiths R.M. du Bois Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension Chest 99 1991 551 556
51. L.E. Odekon F. Blasi D.B. Rifkin Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β J Cell Physiol 158 1994 398 407
52. J. Ohar C. Polatty A. Robichaud The role of vasodilators in patients with progressive systemic sclerosis: Interstitial lung disease and pulmonary hypertension Chest 88 1985 263S 265S
53. T. Ohba J.K. McDonald R.M. Silver Scleroderma BAL fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of the PDGF α receptor Am J Resp Cell Mol Biol 10 1994 405 412
54. K. Ohta R.L. Mortenson R.A.F. Clark Immunohistochemical identification and characterization of smooth muscle-like cells in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 152 1995 1659 1665
55. G.R. Owens I.L. Paradis S. Gryzan Role of inflammation in the lung disease of systemic sclerosis: Comparison with idiopathic pulmonary fibrosis J Lab Clin Med 107 1986 253 260
56. P.F. Piguet M.A. Collart G.E. Grau Requirement of TNF for development of silica-induced pulmonary fibrosis Nature 344 1990 245 247
57. P.F. Piguet M.A. Collart Y. Kapanci TNF plays a key role in bleomycin-induced pneumopathy and fibrosis J Exp Med 170 1989 655 663
58. J. Read H.J.H. Colebatch K.V. Smith Acute diffuse interstitial pulmonary fibrosis in scleroderma Aust Ann Med 9 1960 271 275
59. M. Remy-Jardin F. Giraud J. Remy Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: Pathologic-CT correlation Radiology 189 1993 693 698
60. H.Y. Reynolds J.D. Fulmer J.A. Kazmierowski Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis J Clin Invest 59 1977 165 175
61. G.A. Rossi P.B. Bitterman S.I. Rennard Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis Am Rev Respir Dis 131 1985 612 617
62. R. Salerni G.P. Rodnan D.F. Leon Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma) Ann Intern Med 86 1977 394 399
63. A.P. Sappino I. Masouye J.H. Saurat Smooth muscle differentiation in scleroderma fibroblastic cells Am J Pathol 137 1990 585 591
64. J.R. Seibold R.R. Molony D. Turkevich Acute hemodynamic effects of ketanserin in pulmonary hypertension secondary to systemic sclerosis J Rheumatol 14 1987 519 524
65. P.P. Sfikakis M.K. Kyriakidis C.G. Vergos Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril Am J Med 90 1991 541 546
66. Y. Sibille J.B. Martinot L.L. Polomski Phagocyte enzymes in bronchoalveolar lavage from patients with pulmonary sarcoidosis and collagen vascular disorders Eur Respir J 3 1990 249 256
67. R.M. Silver J.F. Metcalf E.C. LeRoy Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid Arthritis Rheum 29 1986 525 531
68. R.M. Silver J.F. Metcalf J.H. Stanley Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage Arthritis Rheum 27 1984 1254 1262
69. R.M. Silver K.S. Miller M.B. Kinsella Evaluation and management of scleroderma lung disease using bronchoalveolar lavage Am J Med 88 1990 470 475
70. R.M. Silver J.H. Warrick M.B. Kinsella Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease J Rheumatol 20 1993 838 844
71. O. Sitbon F. Brenot A. Denjean Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin Am J Respir Crit Care Med 151 1995 384 389
72. J.W. Smith P.J. Clements J. Levisman Echocardiographic features of progressive systemic sclerosis (PSS): Correlation with hemodynamic and postmortem studies Am J Med 66 1979 28 33
73. A.M. Southcott C.M. Gelder P.J. Barnes T-cell receptor Vα gene usage is not restricted in scleroderma-associated pulmonary fibrosis Arthritis Rheum 36 suppl 1993 S270
74. A.M. Southcott K.P. Jones P. Pantelidis Interleukin-8 is associated with the presence of pulmonary fibrosis in systemic sclerosis Arthritis Rheum 36 suppl 1993 S181
75. T.J. Standiford S.L. Kunkel R.M. Strieter Interleukin-8: A major mediator of acute pulmonary inflammation Reg Immunol 5 1993 134 141
76. T.J. Standiford M.W. Rolfe S.L. Kunkel Macrophage inflammatory protein-1 α expression in interstitial lung disease J Immunol 151 1993 2852 2863
77. V.D. Steen C. Conte G. Owens Natural history of severe pulmonary fibrosis in systemic sclerosis (SSc) Arthritis Rheum 33 1990 S157
78. V.D. Steen G. Graham C. Conte Isolated diffusing capacity reduction in systemic sclerosis Arthritis Rheum 35 1992 765 770
79. V.D. Steen J.K. Lanz C. Conte Therapy for severe interstitial lung disease in systemic sclerosis Arthritis Rheum 37 1994 1290 1296
80. V.D. Steen D.L. Powell T.A. Medsger Jr Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis Arthritis Rheum 31 1988 196 203
81. A.M. Stupi V.D. Steen G.R. Owens Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis Arthritis Rheum 29 1986 515 524
82. W.D. Sullivan D.J. Hurst C.E. Harmon A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease Medicine 63 1984 92 107
83. S.C. Thornton J.M. Robbins R. Penny Fibroblast growth factors in connective tissue disease–associated interstitial lung disease Clin Exp Immunol 90 1992 447 452
84. R.G. Ungerer D.P. Tashkin D. Furst Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis Am J Med 75 1983 65 74
85. R. Vancheeswaran T. Magoulas G. Efrat Circulating endothelin-1 levels in systemic sclerosis subsets—A marker of fibrosis or vascular dysfunction? J Rheumatol 21 1994 1838 1844
86. B. Wallaert F. Bart C. Aerts Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases Thorax 43 1988 24 30
87. B. Wallaert P.Y. Hatron J.M. Grosbois Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function Am Rev Respir Dis 133 1986 574 580
88. D. Wangensteen R. Yankovich J. Hoidal Bleomycin-induced changes in pulmonary microvascular albumin permeability and extravascular albumin space Am Rev Respir Dis 127 1983 204 208
89. J.H. Warrick M. Bhalla S.I. Schabel High-resolution computed tomography in early scleroderma lung disease J Rheumatol 18 1991 1520 1528
90. A.U. Wells M.B. Rubens R.M. duBois Serial CT in fibrosing alveolitis: Prognostic significance of the initial pattern AJR Am J Roentgenol 161 1993 1159 1165
91. R.A. Wise F. Wigley H.H. Newball The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon Chest 81 1982 695 698
92. R.H. Young G.J. Mark Pulmonary vascular changes in scleroderma Am J Med 64 1978 998 1004
93. S.A. Yousem The pulmonary pathologic manifestations of the CREST syndrome Hum Pathol 21 1990 467 474
94. V.V. Yurovsky The repertoire of T-cell receptors in systemic sclerosis Crit Rev Immunol 15 1995 155 165
95. K. Zhang K.C. Flanders S.H. Phan Cellular localization of transforming growth factor-β expression in bleomycin-induced pulmonary fibrosis Am J Pathol 147 1995 352 361